Sign in to continue:

Saturday, July 25th, 2026

Guan Chao Holdings Announces AI Comb Scalp-Care Device Business Plan and Partnership Details (2026)

Guan Chao Holdings Supplemental Announcement: AI Comb Business Collaboration and Strategic Plans

Guan Chao Holdings Releases Supplemental Announcement Detailing AI Comb Business Plans and Potential Collaboration

Guan Chao Holdings Limited has issued a supplemental announcement providing comprehensive details regarding its proposed collaboration with Hangzhou Huashen Network Technology Co., Ltd. for the development and commercialization of a new consumer scalp-care device, the AI Comb. This disclosure follows a previous voluntary announcement and is intended to update shareholders and potential investors on key aspects of the business plan, revenue model, management expertise, capital requirements, and projected sales targets.

Key Highlights of the Announcement

  • Product Innovation: The AI Comb is a next-generation home-use scalp-care device, integrating intelligent hardware and advanced AI models. Its features include automated essential oil dispensing, built-in red-light therapy, AI-driven scalp diagnostics, personalized treatment plans, continuous data tracking, and predictive analytics. The device is designed to transform routine combing into a professional therapeutic experience, with ease-of-use and adaptive care at its core.
  • Business Model: The Company is positioning the AI Comb not as a standalone hardware product, but as the centerpiece of a digital scalp-health management ecosystem. The business aims to transition from one-time device sales to recurring revenues via consumables, subscriptions, in-app microtransactions, and B2B value-added services. Strategic plans include building long-term user lifecycle management and bridging consumer channels with clinical partners.
  • Management Expertise: Key personnel include leaders in strategy, AI product development, technical modeling, and consumer health marketing. Where internal capabilities are limited, the Company plans to leverage external partners for manufacturing, clinical validation, regulatory compliance, and cloud infrastructure.
  • Capital Requirements and Funding: Initial capital will be allocated to hardware tooling, consumable formulation, AI model development, app integration, regulatory matters, marketing, inventory, logistics, and recruitment. Funding for these activities may be sourced from proceeds of a previous share placement (originally earmarked for the hair product business), ongoing operations, and, if needed, secondary equity or debt financing. Shareholders should note that a reallocation of funds may occur, and a further announcement will be made if so.
  • Potential Collaboration Structure: Negotiations are underway for a definitive agreement with Hangzhou Huashen, expected to be structured as either profit-sharing (revenue-sharing) or service payment, without transfer of equity or acquisition of assets. The collaboration will progress through four stages: Sales Proofing, GMV Stabilization, Production-Sales Joint-Building, and GMV Maximization, each with specific targets and payment schedules. Advancement depends on performance metrics and the Company’s right to terminate the agreement.
  • Sales Targets and GMV Projections: For 2026, the sales plan targets 16,200 units (11,340 via Douyin and 4,860 via Tmall) at an ASP of RMB1,299, yielding device GMV of RMB14.7 million and RMB6.3 million respectively. With ancillary sales, the total GMV target is RMB20 million after adjustments. For 2027, the target rises to 71,100 units (49,770 via Douyin, 21,330 via Tmall), with a GMV target of RMB100 million. These figures are illustrative and subject to change based on final agreements.
  • Regulatory and Listing Rule Implications: The Company’s preliminary view is that the collaboration, structured as a commercial contract without an asset or equity transaction, does not trigger notification or approval obligations under Chapter 14 of the Listing Rules. However, if the final structure includes elements qualifying under Chapter 14, the Company will comply with relevant requirements.
  • Risks & Shareholder Advisory: The terms and conditions of the formal agreement have not been finalized. The potential collaboration may or may not proceed. Shareholders and investors are advised to exercise caution when dealing in Company shares.

Implications for Shareholders & Potential Price Sensitivity

  • The AI Comb business represents a strategic shift towards high-tech, recurring revenue scalp-health solutions, which, if successful, could materially enhance profitability, predictability, and customer lifetime value. This transition, combined with the potential reallocation of previously raised funds, and strong sales targets, could be significant for future share performance.
  • The collaboration with Hangzhou Huashen, if finalized, could accelerate product commercialization and market penetration, but risks remain until definitive agreements are signed.
  • Any changes in funding use, sales performance, or regulatory classification under Chapter 14 may be price sensitive and will be disclosed in future announcements.

Board and Management

The Board is led by Co-chairman and Executive Director Tan Shuay Tarng Vincent, supported by a team of experienced executives and independent directors.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell shares. The information herein is based on publicly disclosed documents and may be subject to change pending final agreements and further announcements by Guan Chao Holdings Limited. Investors should monitor official disclosures and exercise caution when making investment decisions.


冠轈控股補充公告:AI智能梳業務合作及戰略計劃詳情(廣東話版)

冠轈控股有限公司發佈補充公告,詳細披露與杭州華深網路科技有限公司合作開發及商業化新消費級頭皮護理設備「AI智能梳」的業務計劃。此公告旨在向股東及潛在投資者更新產品創新、商業模式、管理團隊、資金需求及預期銷售目標等關鍵內容。

公告重點

  • 產品創新:AI智能梳是一款融合智能硬件及先進AI模型的家用頭皮護理產品,具備自動精油分配、紅光療法、AI頭皮分析、個性化治療方案、持續數據追踪及預測分析等功能,令日常梳頭變成專業護理,操作簡單,適應性高。
  • 業務模式:公司將AI智能梳定位為數字化頭皮健康管理生態系統核心,從一次性設備銷售轉型至消耗品訂閱、應用內微交易及B2B增值服務的長期用戶管理及經常性收入模式,並與臨床合作夥伴建立渠道及信譽。
  • 管理團隊:核心人員包括策略總經理、AI產品開發、技術及消費健康營銷領導,能力不足部分會外聘合作夥伴,包括生產、臨床驗證、合規及雲端架構等。
  • 資金需求及來源:初期資金將用於硬件模具、消耗品配方、AI模型開發、應用集成、合規、推廣、庫存、物流及招聘,資金來源包括早前配售所得(原用於護髮產品業務)、現有營運資金,如有需要亦會尋求二次融資。資金用途如有變動會另行公告。
  • 合作結構:與杭州華深洽談最終協議,預期為分成或服務支付模式,無股權或資產轉讓,合作分四階段:銷售驗證、GMV穩定、產銷共建、GMV最大化,進度需達標並有單方終止權。付款方式為固定費加佣金。
  • 銷售目標:2026年計劃銷售16,200台(抖音11,340台、天貓4,860台),均價人民幣1,299元,設備GMV分別為1,470萬及630萬,加上消耗品及應用收入,總GMV目標2,000萬人民幣。2027年目標71,100台,GMV目標1億元。數據僅供參考,最終以協議為準。
  • 合規及上市規則:公司初步認為合作屬商業合同,無資產或股權交易,不觸發第14章公告或批准義務,如最終協議涉及相關元素,會按規則披露。
  • 風險提示:正式協議條款未定,合作未必能成,股東及投資者需謹慎操作公司股份。

對股東及股價的潛在影響

  • AI智能梳業務屬高科技、經常性收入轉型,若成功將提升盈利、預測性及用戶價值,配合資金重新分配及銷售目標,有機會顯著影響股價。
  • 與杭州華深合作若落實,將加速產品上市及市場滲透,但協議未定前仍有風險。
  • 任何資金用途變動、銷售表現或合規分類均屬價格敏感事項,公司會另行公告。

董事會及管理層

董事會由聯席主席兼執行董事陳瑞棠領導,並由多位執行及獨立董事組成。

免責聲明

本文僅供資訊參考,不構成投資建議或買賣邀約。內容以公開披露文件為基礎,最終協議及後續公告或有變動,投資者請留意官方披露並審慎決策。


View GUAN CHAO HLDGS Historical chart here